Genetic Counseling

Pancreatic cancer represents 3% of new cancer cases each year, with the average age of diagnosis being 71 years. Read More ›

The first multigene panels for colorectal cancer became clinically available in 2012. Prior to that date, clinical testing for inherited colorectal cancer syndromes typically proceeded in a sequential fashion. A clinician would develop a differential diagnosis and test corresponding genes in order of those most likely to have a causative mutation. Thus, analyzing multiple genes for inherited colorectal cancer risk was both time intensive and costly. Read More ›

ou may have heard about this gene on the radio or in a news article lately. What’s all the fuss about? On August 7, 2014, the New England Journal of Medicine (NEJM) published an article discussing breast cancer risk in families with mutations in PALB2. Read More ›

In this month’s issue of The Oncology Nurse-APN/PA (TON), we continue our coverage of the news from the recent Oncology Nursing Society (ONS) 39th Annual Congress and the 2014 Annual Meeting of the American Society of Clinical Oncology (ASCO). Read More ›

May 5th is Melanoma Monday, as designated by the American Academy of Dermatology. Read More ›

The majority of hereditary cancer syndromes are inherited in an autosomal dominant fashion. Thus, offspring have a 50% chance of inheriting the condition, as well as a 50% chance of not inheriting it. Read More ›

In 2013 it is estimated that there will be 228,190 new cases and 159,480 deaths due to lung cancer in the United States, making it the leading cause of cancer-related death. Read More ›

The announcement this spring by Angelina Jolie that she had undergone a risk-reducing double mastectomy after learning she carried a mutation in the BRCA1 gene, as well as the recent US Supreme Court decision on gene patenting, has resulted in an influx of questions to both genetic providers and support organizations about hereditary breast cancer. Read More ›

In 2013, approximately 65,000 people will be diagnosed with kidney cancer and two-thirds will be men. Read More ›